Alto Ingredients (ALTO) Insider Dianne Nury Buys 23,605 Shares

Dianne Nury made an insider purchase of 23,605 shares of ALTO on June 23, 2026. This transaction did not involve a pre-planned trading program, suggesting a personal decision to increase her stake in the company.

Other Institutional Activity in ALTO

Several institutional investors have also been active in ALTO. Marshall Wace, LLP increased its holdings by 2,183,218 shares, ending with 3,337,356 shares valued at about $16.15 million, a 189.2% rise. Vanguard Capital Management LLC opened a new position with 3,180,211 shares worth approximately $15.39 million. Two Sigma Investments, LP added 1,167,286 shares, resulting in 2,006,760 shares valued at $9.71 million, marking a 139% increase. Millennium Management LLC significantly boosted its stake by 1,546,477 shares to a total of 1,915,990 shares, valued at $9.27 million, reflecting a 418.5% increase. Arrowstreet Capital, Limited Partnership also grew its holdings by 723,996 shares, ending with 1,790,263 shares worth around $8.66 million, a 67.9% increase.

Alto Ingredients, Inc. Stock Up 24.8%

Shares of ALTO traded near $4.99 on Friday. The stock has seen active trading from both insiders and institutional investors, indicating a keen interest in the company. Despite the lack of detailed financial metrics, the stock's recent trading patterns suggest a dynamic market position.

Insider Buying and Selling at Alto Ingredients, Inc.

In addition to Dianne Nury, several other insiders were active. On June 23, 2026, Nathan Gilbert, Tank Alan Robert, and Maria Gray each purchased 23,605 shares. There was also a previous purchase by Nathan Gilbert on May 13, 2026, of 5,000 shares at an average price of $4.45. Conversely, Graham Auste sold 20,000 shares on May 14, 2026.

Analysts Set New Price Targets

On May 7, 2026, HC Wainwright & Co. maintained its buy rating on ALTO with a price target of $10. The firm has consistently supported the stock with a buy rating over several past evaluations. The consensus among analysts remains positive, with strong buy recommendations and a mean target price indicating potential upside.

Bottom Line

Dianne Nury's recent purchase of ALTO shares aligns with significant institutional interest, highlighting a potential positive outlook for the company. While 13F filings and insider transactions offer a backward look at investment moves, they can provide insights into investor sentiment and company prospects. ALTO's trading activity and analyst ratings suggest it remains a stock to watch.